Summit ivonescimab shows OS hazard ratio of 0.76 in lung cancer trial
Go back to Summit ivonescimab shows OS hazard ratio of 0.76 in lung cancer trial| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 17.56 -0.16 (0.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.72 | 52 Week High | $19.75 | |||
| Open | $17.74 | 52 Week Low | $4.26 | |||
| Day High | $17.83 | P/E | N/A | |||
| Day Low | $17.31 | EPS | $0.00 | |||
| Volume | 1,387,035 | |||||
